Identifying and Managing nmCRPC Patients in the Era of PSMA-PET Imaging

7 Dec 2021Oncology

Kirsty LEE

This content is sponsored. It is intended for healthcare professionals only.

Case 1 was a 77-year-old retired lawyer, with a previous medical history of hypertension, hypercholesterolemia, gout and multiple skin squamous cell carcinomas. He underwent salvage radiotherapy and short course androgen deprivation therapy (ADT) in 2015 and commenced ADT in 2017 when prostate-specific antigen (PSA) levels >2ng/mL and an increased doubling time of 8 months.

Identifying-and-Managing-nmCRPC-Patients-in-the-Era-of-PSMA-PET-Imaging

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Identifying and Managing nmCRPC Patients in the Era of PSMA-PET Imaging

Related posts